Tag: Schedule K
-
Nimesulide Ban and Cough Syrup OTC Scrutiny: What the New Policy Means
Overview: What is Changing? The health ministry has announced two concurrent regulatory moves that could reshape how common medicines reach consumers. First, Nimesulide in doses above 100 mg faces a ban in over‑the‑counter (OTC) sale, signaling tighter controls on non-prescription anti‑inflammatory drugs. Second, a proposed draft notification would remove cough syrups from the list of…
-
Nimesulide Ban Over 100 mg and Cough Syrup Sale Restrictions: What It Means for Consumers
New Drug Policy Moves Target Nimesulide and Cough Syrups The government has announced two significant regulatory changes aimed at tightening drug safety and access. First, products containing nimesulide at doses exceeding 100 mg are being banned. Second, a draft notification proposes removing cough syrups from the list of over-the-counter (OTC) medicines, effectively making them prescription-only.…